Quantification of von Willebrand Factor and von Willebrand Factor Propeptide in Patients with End Stage Renal Disease

被引：0

作者：

Davis, Rachael ^{[1
]}

Bansal, Vinod ^{[1
]}

Litinas, Evangelos ^{[1
]}

Rahman, Saudur ^{[1
]}

Hoppensteadt, Debra ^{[1
]}

Conway, Brooke ^{[2
]}

Fareed, Jawed ^{[1
]}

机构：

[1] Loyola Univ, Med Ctr, Maywood, IL 60153 USA

[2] GTI Diagnost, Waukesha, WI USA

来源：

FASEB JOURNAL | 2010年 / 24卷

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页数：1

共 50 条

[41] Von Willebrand factor propeptide compared to von Willebrand factor as plasma marker of endothelial activation in systemic sclerosis. [J].

Scheja, A ;

Wildt, M ;

Wollheim, F ;

Akesson, A ;

Vischer, U .

ARTHRITIS AND RHEUMATISM, 1999, 42 (09) :S207-S207

[42] von Willebrand factor alloantibodies in type 3 von Willebrand disease [J].

Kotnik, Barbara Faganel ;

Strandberg, Karin ;

Debeljak, Marusa ;

Kitanovski, Lidija ;

Jazbec, Janez ;

Benedik-Dolnicar, Majda ;

Bakija, Alenka Trampus .

BLOOD COAGULATION & FIBRINOLYSIS, 2020, 31 (01) :77-79

[43] Von Willebrand factor contribution to pathophysiology outside of von Willebrand disease [J].

Mojiri, Anahita ;

Alavi, Parnian ;

Jahroudi, Nadia .

MICROCIRCULATION, 2019, 26 (04)

[44] Genome-wide studies of von Willebrand factor propeptide identify loci contributing to variation in propeptide levels and von Willebrand factor clearance [J].

Ozel, A. B. ;

McGee, B. ;

Siemieniak, D. ;

Jacobi, P. M. ;

Haberichter, S. L. ;

Brody, L. C. ;

Mills, J. L. ;

Molloy, A. M. ;

Ginsburg, D. ;

Li, J. Z. ;

Desch, K. C. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (09) :1888-1898

[45] Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A [J].

Castaman, Giancarlo ;

Linari, Silvia .

THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 :1029-1037

[46] Profile of von Willebrand factor antigen & von Willebrand factor propeptide in an overall population of TIA and ischaemic stroke patients and in specific TOAST subgroups [J].

Tobin, W. O. ;

Kinsella, J. A. ;

Kavanagh, G. F. ;

O'Donnell, J. S. ;

McGrath, R. A. ;

Collins, D. R. ;

Coughlan, T. ;

O'Neill, D. ;

Egan, B. ;

Tierney, S. ;

Feeley, T. M. ;

Murphy, R. P. ;

McCabe, D. J. H. .

CEREBROVASCULAR DISEASES, 2013, 35 :550-550

[47] von Willebrand Factor Antigen, von Willebrand Factor Propeptide, and ADAMTS13 in Carotid Stenosis and Their Relationship with Cerebral Microemboli [J].

Murphy, Stephen J. X. ;

Lim, Soon Tjin ;

Hickey, Fionnuala ;

Kinsella, Justin A. ;

Smith, Deirdre R. ;

Tierney, Sean ;

Egan, Bridget ;

Feeley, T. Martin ;

Murphy, Sinead M. ;

Collins, D. Ronan ;

Coughlan, Tara ;

O'Neill, Desmond ;

Harbison, Joseph A. ;

Madhavan, Prakash ;

O'Neill, Sean M. ;

Colgan, Mary-Paula ;

O'Donnell, James S. ;

O'Sullivan, Jamie M. ;

Hamilton, George ;

McCabe, Dominick J. H. .

THROMBOSIS AND HAEMOSTASIS, 2021, 121 (01) :86-97

[48] The Use of Phage Display and Yeast Based Expression System for the Development of a Von Willebrand Factor Propeptide Assay: Development of a Von Willebrand Factor Propeptide Assay [J].

Meiring, S. M. ;

Setlai, B. D. P. ;

Theron, C. ;

Bragg, R. .

BIOMED RESEARCH INTERNATIONAL, 2018, 2018

[49] Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes [J].

Tobin, W. O. ;

Kinsella, J. A. ;

Kavanagh, G. F. ;

O'Donnell, J. S. ;

McGrath, R. T. ;

Tierney, S. ;

Egan, B. ;

Feeley, T. M. ;

Coughlan, T. ;

Collins, D. R. ;

O'Neill, D. ;

Murphy, S. J. X. ;

Lim, S. J. ;

Murphy, R. P. ;

McCabe, D. J. H. .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 375 :404-410

[50] Toward Personalized Treatment for Patients with Low von Willebrand Factor and Quantitative von Willebrand Disease [J].

O'Donnell, James S. .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2021, 47 (02) :192-200

← 1 2 3 4 5 →